Zevra Therapeutics (ZVRA) Long-Term Investments (2016 - 2026)
Zevra Therapeutics (ZVRA) reported Long-Term Investments of $38.61 million for Q2 2026, up 155.9% from $15.09 million a year earlier and up 6.8% from the prior quarter.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) Long-Term Investments (2016 - 2026) Analysis & Trends
At the end of FY2025, Zevra Therapeutics posted Long-Term Investments of $47.88 million, up 696.7% from FY2024.
- Long-Term Investments has a four-year compound annual growth rate of 33.8% (FY2021 to FY2025).
- By year, Long-Term Investments came in at $6.01 million in FY2024, $20 million in FY2022 (+33.9%) and $14.93 million in FY2021.
- Five-year quarterly Long-Term Investments spans a low of $6.01 million in Q4 2024 and a high of $47.88 million in Q4 2025.
- Year over year, Long-Term Investments has now increased in each of the last four quarters, with growth averaging 437.9% over the last four quarters.
- Per Business Quant data, the three quarters before Q2 2026 came in at $36.15 million (Q1 2026), $47.88 million (Q4 2025) and $30.87 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.86 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 266.00 Mn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 1.22 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 69.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.62 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 1.56 Bn |
| 10 | Zevra Therapeutics | 592.83 Mn | -219.88 Mn | 38.18 Mn | 38.61 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 38.61 Mn |
| Mar 31, 2026 | 36.15 Mn |
| Dec 31, 2025 | 47.88 Mn |
| Sep 30, 2025 | 30.87 Mn |
| Jun 30, 2025 | 15.09 Mn |
| Mar 31, 2025 | 6.09 Mn |
| Dec 31, 2024 | 6.01 Mn |
| Sep 30, 2024 | 6.11 Mn |
| Dec 31, 2022 | 20.00 Mn |
| Sep 30, 2022 | 31.46 Mn |
| Jun 30, 2022 | 33.54 Mn |
| Mar 31, 2022 | 17.56 Mn |
| Dec 31, 2021 | 14.93 Mn |
| Dec 31, 2017 | 3.25 Mn |
| Sep 30, 2017 | 6.72 Mn |
| Jun 30, 2017 | 11.22 Mn |
| Mar 31, 2017 | 10.16 Mn |
| Dec 31, 2016 | 8.20 Mn |
| Sep 30, 2016 | 27.36 Mn |
| Jun 30, 2016 | 18.85 Mn |
API Access
Zevra Therapeutics Long-Term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-investments&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-investments", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-investments&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();